Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Brent Ahrens
AddedMar 31, 2024
UpdatedMay 31, 2026
Brent Ahrens

Brent Ahrens

Board Member, Abyrx

Crunchbase

Brent Ahrens's Career

Abyrx
Abyrx

Irvington, NY, US

Board Member· Board
Kalidex Pharmaceuticals
Kalidex Pharmaceuticals

Menlo Park, CA, US

Board Member· Board
Pavad Medical
Pavad Medical

Fremont, CA, US

Board Member· Board
Minimally Invasive Devices
Minimally Invasive Devices

Columbus, OH, US

Board Member· Board
Novare Surgical Systems
Novare Surgical Systems

Cupertino, CA, US

Board Member· Board
Relievant Medsystems
Relievant Medsystems

Edina, MN, US

Board Member· Board
EndoGastric Solutions
EndoGastric Solutions

Redmond, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Brent Ahrens's Career

Abyrx
Abyrx

Irvington, NY, US

Board Member· Board
Kalidex Pharmaceuticals
Kalidex Pharmaceuticals

Menlo Park, CA, US

Board Member· Board
Pavad Medical
Pavad Medical
Series C$23.6M302002Fremont, CA, US
Board Member· Board

Leadership at Pavad Medical

Charles T Liamos \"Charlie\"Charles T Liamos \"Charlie\"Board Member
Minimally Invasive Devices
Minimally Invasive Devices
Public$47.1M332009Columbus, OH, US
Board Member· Board

Leadership at Minimally Invasive Devices

Wende HuttonWende HuttonBoard Member
Mike HoovenMike HoovenBoard Member
Fred M. SchwarzerFred M. SchwarzerBoard Member
Wayne PollWayne PollFounder
Jeff RydinJeff RydinBoard Member

Similar to Minimally Invasive Devices

Agile EndoSurgeryAgile EndoSurgeryChapel Hill, NC, USSurgical Instrumentsest. 2010Agile EndoSurgeryChapel Hill, NC, US · est. 2010

Agile EndoSurgery, based in Durham, US, develops advanced surgical tools to enhance minimally invasive surgery.

Seed · $258.7k5
Novare Surgical Systems
Novare Surgical Systems
Acquired$25.8M01999Cupertino, CA, US
Board Member· Board

Leadership at Novare Surgical Systems

Ed ChangEd ChangBoard Member
Allan WillAllan WillBoard Member
Tom FogartyTom FogartyBoard Member
Delos CosgroveDelos CosgroveBoard Member

Similar to Novare Surgical Systems

NovaTract SurgicalNovaTract SurgicalMadison, CT, USMedical Devicesest. 2010NovaTract SurgicalMadison, CT, US · est. 2010

NovaTract Surgical develops laparoscopic devices for minimally invasive surgeries across the US.

Series A · $4.7M8
Minimally Invasive DevicesMinimally Invasive DevicesColumbus, OH, USSurgical Devicesest. 2009Minimally Invasive DevicesColumbus, OH, US · est. 2009

Developing surgical tools for enhanced visualization in minimally invasive surgeries across the US.

Public · $47.1M33
Relievant Medsystems
Relievant Medsystems
Public$273.6M592006Edina, MN, US
Board Member· Board

Leadership at Relievant Medsystems

Tyler BinneyTyler BinneyCEO
Kevin HykesKevin HykesBoard Member
Justin KleinJustin KleinBoard Member
Jason LettmannJason LettmannBoard Member
Samit PatelSamit PatelFounder

Similar to Relievant Medsystems

Relevium MedicalRelevium MedicalGalway, County Galway, IEPain Treatmentsest. 2019Relevium MedicalGalway, County Galway, IE · est. 2019

Innovative biopharmaceutical company providing superior pain treatments.

Public4
RaymedicaRaymedicaMinneapolis, MN, USMedical Devicesest. 1990RaymedicaMinneapolis, MN, US · est. 1990

Raymedica, Inc. is a medical device manufacturer, innovating surgical solutions for low back pain treatment worldwide.

Series A · $10M30
Channel MedsystemsChannel MedsystemsSan Francisco, CA, USMedical Devicesest. 2009Channel MedsystemsSan Francisco, CA, US · est. 2009

San Francisco-based Channel Medsystems develops and delivers non-invasive medical technology products.

Series A · $62.9M35
EndoGastric Solutions
EndoGastric Solutions
Series B$380.2M922003Redmond, WA, US
Board Member· Board

Leadership at EndoGastric Solutions

Arda MinocherhomjeeArda MinocherhomjeeBoard Member
Darin HammersDarin HammersBoard Member
Jordan S. DavisJordan S. DavisBoard Member
Alejandro SanchezAlejandro SanchezBoard Member
Joe MandatoJoe MandatoBoard Member
Mike CarusiMike CarusiBoard Member

Similar to EndoGastric Solutions

EndoSoundEndoSoundPortland, OR, USMedical Devicesest. 2016EndoSoundPortland, OR, US · est. 2016

EndoSound: Pioneering technology for advanced endoscopic ultrasound solutions.

Angel · $410.8k12
EvoEndoEvoEndoEnglewood, CO, USMedical Devicesest. 2017EvoEndoEnglewood, CO, US · est. 2017

EvoEndo: Innovating unsedated endoscopic procedures with sterile, single-use systems.

Series B · $19M16

Brent Ahrens's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Brent Ahrens

Joel HolsingerJoel HolsingerBoard Member · PathHarrison BainsHarrison BainsBoard Member · BG MedicineChristian ArmstrongChristian ArmstrongCo-Founder · Medpac TechnologiesJosh BrunoJosh BrunoCEO · CareGuardianDanny GutknechtDanny GutknechtCEO · PathwaysAlex SchachneAlex SchachneCo-Founder · Leap AI